Poll: Will You Recommend Triptorelin to Reproductive-Age Patients With Breast Cancer?
August 2nd 2011Researchers from Italy have found that premenopausal breast cancer patients treated with triptorelin and chemotherapy were less likely to experience early menopause and were more likely to resume menses than patients who received chemotherapy alone.
Putting Women's Health First Aims to Educate Women
August 2nd 2011Today, Putting Women's Health First launched a national campaign to educate women about cervical cancer, the role of human papillomavirus (HPV) role in its development, and the importance of effective screening in preventing the disease.
Triptorelin Reduces the Risk of Chemotherapy-Induced Early Menopause
August 2nd 2011The use of chemotherapy for the treatment of breast cancer can result in transient or permanent amenorrhea, and research indicates that each month of chemotherapy translates into 1.5 year of lost reproductive life. This is especially significant for women younger than 40 years, which accounts for 6% of the population diagnosed with breast cancer.
Beta Blocker Use May Confer Protective Properties for Women With Breast Cancer
August 2nd 2011Recent studies have indicated that β-adrenergic signaling is involved in the regulation of immune responses to breast tumor cells, and data from in vivo studies show an association between β-adrenergic signaling with increased nodal involvement and development of metastasis but no effect on primary tumor growth. Based on this evidence, Dr Thomas I. Barron, from the department of pharmacology and therapeutics at Trinity Centre for Health Sciences, in Dublin, Ireland, and colleagues chose to explore the relationship between beta blocker use and breast tumor characteristics as well as breast cancer morbidity.
Use of emergency contraception is increasing in the United States
August 1st 2011Analysis of data from the 2006-2008 National Survey of Family Growth reveals that use of emergency contraception in the US has more than doubled since 2002, from 4.2% to 9.7%, but remains highly dependent on whether physicians provide counseling about EC.
Did physician's failure to communicate biopsy results lead to patient's death?
August 1st 2011A Virginia woman went to her gynecologist for an annual physical. The pap smear revealed human papillomavirus and abnormal cells. A cone biopsy was performed and the pathology report from the biopsy revealed adenoid cystic carcinoma. However, the gynecologist did not tell the patient about the cervical cancer; instead she was told to undergo a hysterectomy.
Another disappointment for ovarian cancer screening
August 1st 2011Those who had hoped that the combination of routine screening with cancer antigen 125 (CA-125) and pelvic ultrasound would promote an earlier diagnosis and improved survival for women with ovarian cancer were dealt a harsh blow when the PLCO trail results were reported.